Pulse Biosciences (NASDAQ:PLSE) Trading Down 5.4% – Here’s Why

Pulse Biosciences, Inc. (NASDAQ:PLSE)’s share price fell 5.4% during mid-day trading on Tuesday . The stock traded as low as $17.68 and last traded at $17.72. 26,205 shares changed hands during trading, a decline of 87% from the average session volume of 199,654 shares. The stock had previously closed at $18.73.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Pulse Biosciences to a “sell” rating in a report on Wednesday, November 27th.

Pulse Biosciences Trading Down 7.0 %

The firm’s fifty day simple moving average is $17.61 and its 200 day simple moving average is $16.31.

Pulse Biosciences (NASDAQ:PLSE) last issued its quarterly earnings data on Wednesday, October 30th. The company reported ($0.21) earnings per share (EPS) for the quarter. During the same period last year, the firm earned ($0.19) earnings per share.

Hedge Funds Weigh In On Pulse Biosciences

Institutional investors and hedge funds have recently made changes to their positions in the business. Price T Rowe Associates Inc. MD bought a new position in Pulse Biosciences during the 1st quarter valued at about $88,000. Quest Partners LLC bought a new position in shares of Pulse Biosciences in the second quarter worth about $91,000. Cetera Advisors LLC bought a new stake in Pulse Biosciences during the 1st quarter valued at about $109,000. Rhumbline Advisers boosted its position in Pulse Biosciences by 6.7% in the 2nd quarter. Rhumbline Advisers now owns 25,729 shares of the company’s stock valued at $288,000 after buying an additional 1,608 shares during the period. Finally, Franklin Resources Inc. bought a new position in Pulse Biosciences in the 3rd quarter worth about $378,000. 76.95% of the stock is owned by hedge funds and other institutional investors.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.